CM

Christopher Marohnic

Abbott: 9 patents #708 of 5,431Top 15%
IS Icahn School Of Medicine At Mount Sinai: 1 patents #161 of 404Top 40%
Overall (All Time): #556,468 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11428694 Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies Robert N. Ziemann, April Ahlberg, David J. Hawksworth, Bryan C. Tieman, A. Scott Muerhoff +1 more 2022-08-30
11340230 Subject anti-HCV antibody detection assays employing NS3 capture peptides Anthony S. Muerhoff, John Prostko 2022-05-24
10816551 Subject anti-HCV antibody detection assays employing NS3 capture peptides Anthony S. Muerhoff, John Prostko 2020-10-27
10444242 Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies Robert N. Ziemann, April Ahlberg, David J. Hawksworth, Bryan C. Tieman, A. Scott Muerhoff +3 more 2019-10-15
10345311 Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodies Robert N. Ziemann, April Ahlberg, David J. Hawksworth, Bryan C. Tieman, A. Scott Muerhoff +1 more 2019-07-09
10197573 HCV core lipid binding domain monoclonal antibodies Robert N. Ziemann, April Ahlberg, David J. Hawksworth, Bryan C. Tieman, A. Scott Muerhoff +1 more 2019-02-05
9841427 HCV antigen-antibody combination assay and methods and compositions for use therein George J. Dawson, Suresh M. Desai, Robin A. Gutierrez, A. Scott Muerhoff, John Prostko +1 more 2017-12-12
9790478 HCV NS3 recombinant antigens and mutants thereof for improved antibody detection A. Scott Muerhoff, Larry G. Birkenmeyer, John Prostko, M. Felisha Bogdan, Robin A. Gutierrez 2017-10-17
9371374 HCV core lipid binding domain monoclonal antibodies Robert N. Ziemann, April Ahlberg, David J. Hawksworth, Bryan C. Tieman, A. Scott Muerhoff +1 more 2016-06-21